Publications
Export 9 results:
Filters: Author is Urushitani, Makoto [Clear All Filters]
, “Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.”, Glia, vol. 58, no. 2, pp. 231-43, 2010.
, “Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.”, J Neuropathol Exp Neurol, vol. 69, no. 10, pp. 1044-56, 2010.
, “Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.”, J Neurochem, vol. 115, no. 5, pp. 1102-11, 2010.
, “Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 106, no. 51, pp. 21777-82, 2009.
, “Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish.”, Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
, “The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS.”, FASEB J, vol. 22, no. 7, pp. 2476-87, 2008.
, “Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 104, no. 7, pp. 2495-500, 2007.
, “Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation.”, J Neurochem, vol. 102, no. 1, pp. 170-8, 2007.
, “Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.”, Nat Neurosci, vol. 9, no. 1, pp. 108-18, 2006.
